Lipe & Dalton’s Brookfield BN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.02M | Sell |
164,830
-3,806
| -2% | -$170K | 3.26% | 6 |
|
|
2026
Q1 | $6.83M | Sell |
168,636
-350
| -0.2% | -$15.5K | 3.57% | 6 |
|
|
2025
Q4 | $7.75M | Sell |
168,986
-3,864
| -2% | -$176K | 3.83% | 5 |
|
|
2025
Q3 | $7.9M | Sell |
172,850
-7,738
| -4% | -$343K | 3.92% | 5 |
|
|
2025
Q2 | $7.45M | Sell |
180,588
-5,204
| -3% | -$193K | 4.02% | 4 |
|
|
2025
Q1 | $6.49M | Sell |
185,792
-4,861
| -3% | -$184K | 3.63% | 4 |
|
|
2024
Q4 | $7.3M | Sell |
190,653
-438
| -0.2% | -$16.5K | 3.87% | 5 |
|
|
2024
Q3 | $6.77M | Sell |
191,091
-405
| -0.2% | -$12.8K | 3.42% | 5 |
|
|
2024
Q2 | $5.3M | Sell |
191,496
-6,170
| -3% | -$172K | 2.85% | 8 |
|
|
2024
Q1 | $5.52M | Buy |
197,666
+161
| +0.1% | +$4.34K | 2.84% | 10 |
|
|
2023
Q4 | $5.28M | Hold |
197,505
| – | – | 2.87% | 10 |
|
|
2023
Q3 | $4.12M | Sell |
197,505
-299
| -0.2% | -$6.74K | 2.48% | 12 |
|
|
2023
Q2 | $4.44M | Sell |
197,804
-1,786
| -0.9% | -$37.9K | 2.53% | 11 |
|
|
2023
Q1 | $4.34M | Sell |
199,590
-4,892
| -2% | -$110K | 2.48% | 13 |
|
|
2022
Q4 | $4.29M | Sell |
204,482
-50,373
| -20% | -$1.13M | 2.47% | 15 |
|
|
2022
Q3 | $5.62M | Sell |
254,855
-180
| -0.1% | -$4.66K | 3.52% | 5 |
|
|
2022
Q2 | $6.11M | Sell |
255,035
-345
| -0.1% | -$9.22K | 3.58% | 4 |
|
|
2022
Q1 | $7.79M | Sell |
255,380
-4,767
| -2% | -$143K | 3.8% | 3 |
|
|
2021
Q4 | $8.46M | Buy |
260,147
+1,277
| +0.5% | +$40.4K | 4% | 3 |
|
|
2021
Q3 | $7.46M | Sell |
258,870
-1,945
| -0.7% | -$56.8K | 3.84% | 5 |
|
|
2021
Q2 | $7.17M | Sell |
260,815
-983
| -0.4% | -$25.2K | 3.73% | 4 |
|
|
2021
Q1 | $6.24M | Sell |
261,798
-5,803
| -2% | -$129K | 3.46% | 6 |
|
|
2020
Q4 | $5.91M | Sell |
267,601
-634
| -0.2% | -$12.7K | 3.63% | 3 |
|
|
2020
Q3 | $4.75M | Sell |
268,235
-183
| -0.1% | -$3.27K | 3.3% | 6 |
|
|
2020
Q2 | $4.73M | Sell |
268,418
-2,458
| -0.9% | -$43.2K | 3.43% | 4 |
|
|
2020
Q1 | $4.28M | Sell |
270,876
-5,908
| -2% | -$122K | 3.62% | 4 |
|
|
2019
Q4 | $5.71M | Sell |
276,784
-2,943
| -1% | -$58.7K | 3.78% | 4 |
|
|
2019
Q3 | $5.3M | Sell |
279,727
-6,477
| -2% | -$117K | 3.87% | 3 |
|
|
2019
Q2 | $4.88M | Sell |
286,204
-2,096
| -0.7% | -$35.5K | 3.49% | 7 |
|
|
2019
Q1 | $4.8M | Sell |
288,300
-381
| -0.1% | -$5.93K | 3.53% | 7 |
|
|
2018
Q4 | $3.95M | Sell |
288,681
-1,962
| -0.7% | -$29.3K | 3.22% | 10 |
|
|
2018
Q3 | $4.62M | Buy |
290,643
+12,679
| +5% | +$193K | 3.15% | 11 |
|
|
2018
Q2 | $4.02M | Buy |
277,964
+1,368
| +0.5% | +$19.5K | 2.96% | 13 |
|
|
2018
Q1 | $3.85M | Buy |
276,596
+1,191
| +0.4% | +$17.2K | 2.75% | 15 |
|
|
2017
Q4 | $4.28M | Sell |
275,405
-1,934
| -0.7% | -$29.2K | 2.96% | 13 |
|
|
2017
Q3 | $4.09M | Buy |
277,339
+765
| +0.3% | +$10.7K | 2.87% | 14 |
|
|
2017
Q2 | $3.87M | Buy |
276,574
+1,242
| +0.5% | +$16.7K | 2.51% | 14 |
|
|
2017
Q1 | $3.58M | Sell |
275,332
-5,126
| -2% | -$65K | 2.59% | 16 |
|
|
2016
Q4 | $3.3M | Sell |
280,458
-1,051
| -0.4% | -$12.8K | 2.35% | 19 |
|
|
2016
Q3 | $3.53M | Sell |
281,509
-1,399
| -0.5% | -$17.1K | 2.37% | 17 |
|
|
2016
Q2 | $3.34M | Sell |
282,908
-159,366
| -36% | -$1.91M | 2.3% | 17 |
|
|
2016
Q1 | $5.4M | Sell |
442,274
-7,364
| -2% | -$79.3K | 4.25% | 3 |
|
|
2015
Q4 | $4.98M | Sell |
449,638
-6,635
| -1% | -$77.8K | 4.03% | 5 |
|
|
2015
Q3 | $5.04M | Sell |
456,273
-14,745
| -3% | -$172K | 4.18% | 2 |
|
|
2015
Q2 | $5.78M | Sell |
471,018
-20,232
| -4% | -$258K | 4.14% | 2 |
|
|
2015
Q1 | $6.17M | Buy |
+491,250
| New | +$6.09M | 4.25% | 2 |
|
Other funds holding BN
PVI
PSCM
BC
Lipe & Dalton's BN Position: Q2 2026 in Review
Lipe & Dalton reduced its Brookfield (BN) stake by 2.3% in Q2 2026, selling an estimated $170K and leaving 164,830 shares worth $7.02M. The position accounts for 3.26% of the portfolio, ranked #6.
Lipe & Dalton first reported a position in BN in Q1 2015 and has held it in 46 quarters since. The position peaked at $8.46M in Q4 2021. 940 funds tracked by Wall St. Rank hold BN as of Q2 2026.
- Lipe & Dalton held 164,830 shares of Brookfield worth $7.02M as of Q2 2026.
- Lipe & Dalton sold 3,806 Brookfield shares in Q2 2026, an estimated $170K.
- Brookfield made up 3.26% of Lipe & Dalton's portfolio in Q2 2026, its #6 holding.
- Lipe & Dalton first reported a position in Brookfield in Q1 2015 and has held it in 46 quarters since.
- Lipe & Dalton's Brookfield position peaked at $8.46M in Q4 2021.
- 940 funds tracked by Wall St. Rank held Brookfield as of Q2 2026.
Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.